Navidea Biopharmaceuticals, Inc. (NAVB)
OTCMKTS: NAVB · Delayed Price · USD
0.0370
+0.0002 (0.54%)
Apr 24, 2024, 9:35 AM EDT - Market open

NAVB Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016201520142013 2012 - 1992
Cash & Equivalents
24.232.671.053.484.591.547.175.4832.94
Upgrade
Short-Term Investments
00000.81.80000
Upgrade
Cash & Cash Equivalents
24.232.671.054.284.591.547.175.4832.94
Upgrade
Cash Growth
-52.83%58.43%155.02%-75.51%-6.91%198.35%-78.52%30.79%-83.37%261.23%
Upgrade
Receivables
00.092.990.90.028.141.83.70.821.15
Upgrade
Inventory
0.430.150.17-0.9001.470.650.932.23
Upgrade
Other Current Assets
0.780.910.71.870.68-0.76.011.051.371.01
Upgrade
Total Current Assets
3.25.386.532.924.9713.8310.8312.588.637.33
Upgrade
Property, Plant & Equipment
0.160.250.380.310.160.241.251.932.512.13
Upgrade
Long-Term Investments
000000000.240
Upgrade
Intangible Assets
10.790.620.390.430.460.180.190.180.14
Upgrade
Other Long-Term Assets
0.010.230.230.541.446.250.20.270.390.72
Upgrade
Total Long-Term Assets
1.171.261.231.242.036.951.642.393.322.99
Upgrade
Total Assets
4.376.647.764.157.0120.7812.4614.9611.9240.32
Upgrade
Accounts Payable
2.121.421.161.110.420.867.121.771.482.42
Upgrade
Deferred Revenue
0.80.70.70.70.87-0.862.321.04-1.48-2.42
Upgrade
Current Debt
0.560.731.040.560.322.3551.960.334.384.1
Upgrade
Other Current Liabilities
6.462.451.811.451.775.718.473.044.717.2
Upgrade
Total Current Liabilities
9.945.34.723.823.388.0769.866.189.111.29
Upgrade
Long-Term Debt
1.870.020.30.510.47588.099.6460.7529.5423.57
Upgrade
Other Long-Term Liabilities
0.70.70.70.70.76-587.430.621.873.099.46
Upgrade
Total Long-Term Liabilities
2.570.7211.211.230.6610.2762.6232.6333.04
Upgrade
Total Liabilities
12.516.025.715.034.618.7380.1368.841.7244.33
Upgrade
Total Debt
2.430.751.341.070.322.3561.661.0833.9227.67
Upgrade
Debt Growth
224.82%-43.92%25.03%238.17%-86.57%-96.18%0.85%80.05%22.60%185.63%
Upgrade
Common Stock
0.220.220.220.210.20.160.160.160.150.14
Upgrade
Retained Earnings
-388-370.79-359.06-347.67-336.72-319.91-394.86-380.55-352.98-317.26
Upgrade
Comprehensive Income
00-4.970-0-0-2.33-1.94-1.61-1.48
Upgrade
Shareholders' Equity
-8.44-0.111.32-1.611.7311.38-68.14-54.31-29.8-4.01
Upgrade
Total Liabilities and Equity
4.376.647.764.157.0120.7812.4614.9611.9240.32
Upgrade
Net Cash / Debt
-0.443.481.33-0.023.964.04-60.06-53.91-28.445.27
Upgrade
Net Cash / Debt Growth
-160.96%---1.92%-----
Upgrade
Net Cash Per Share
-0.010.120.06-0.000.460.49-7.73-7.13-3.820.87
Upgrade
Working Capital
-6.740.081.81-0.91.65.76-59.046.39-0.526.04
Upgrade
Book Value Per Share
-0.29-0.000.06-0.110.201.41-8.77-7.18-4.01-0.66
Upgrade
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.